Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillatio
Not Applicable
- Conditions
- Paroxysmal atrial fibrillation Renal disease
- Registration Number
- JPRN-UMIN000018365
- Lead Sponsor
- Osaka General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
a. Patients with non-valvular atrial fibrillation, after open heart surgery b. NYHA III or IV c. Peritoneal dialysis patients d. Patients who were judged inappropriate by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence within one year from the first ablation
- Secondary Outcome Measures
Name Time Method i) Recurrence within one year from the last ablation ii) Procedure time, fluoroscopic time, complications iii) Pulmonary congestion necessary to extend hospital stay iv) Increase in weight after ablation v) Unscheduled hemodialysis vi) Cerebral infarction, systemic thromboembolism vii) All-cause death, cardiac death, sudden death